Press releases, partnership announcements, milestone achievements, and conference appearances from AlphaMeld and InveniAI.
GUILFORD, Conn., June 10, 2025 (GLOBE NEWSWIRE) — AlphaMeld Corporation, a global frontrunner in AI-powered drug discovery, and VedTechBio Research Pvt. Ltd., an emerging biopharma technology innovato…
READ →GUILFORD, Conn., Jan. 28, 2025 (GLOBE NEWSWIRE) — AlphaMeld Corporation, a global leader in the application of artificial intelligence (AI), machine learning (ML), and generative AI tools to revolutio…
READ →GUILFORD, Conn., Jan 13, 2025 — InveniAI LLC, a global leader in the application of artificial intelligence (AI), machine learning (ML), and generative AI tools to revolutionize drug discovery and dev…
READ →Guilford, Conn. — February 19, 2024 — InveniAI LLC, a global leader in the application of artificial intelligence (AI) and machine learning (ML) tools to revolutionize drug discovery and development, …
READ →Guilford, Conn. — April 4, 2023 — InveniAI® LLC, a global leader in leveraging AI and machine learning (ML) to transform innovation in drug discovery and development, announces the introduction of Cha…
READ →GUILFORD, Conn. and TOKYO, May 31, 2022 — InveniAI® LLC, a global leader in applying Artificial Intelligence (AI) and Machine Learning (ML) to transform drug and target discovery and development, and …
READ →GUILFORD, Conn. USA, February 24, 2022 — InveniAI® LLC, a global leader in applying Artificial Intelligence (AI) and Machine Learning (ML) to transform drug discovery and development, today announced …
READ →GUILFORD, Conn. USA, and TOKYO, Japan, December 16, 2021 — InveniAI® LLC, a global leader in applying Artificial Intelligence (AI) and Machine Learning (ML) to transform drug discovery and development…
READ →Guilford, Conn., July 20, 2021 — InveniAI® LLC (InveniAI), a global leader in applying artificial intelligence (AI) and machine learning (ML) to transform drug discovery and development, today announc…
READ →TOKYO and CAMBRIDGE, United Kingdom and GUILFORD, Conn., 6 July 2021 — Sosei Group Corporation, the world leader in GPCR-focused Structure-Based Drug Design and Development (SBDD), and InveniAI® LLC, …
READ →GUILFORD, Conn., May 11, 2021 (GLOBE NEWSWIRE) — InveniAI® LLC, a global leader in pioneering the application of artificial intelligence (AI) and machine learning (ML) to transform innovation across d…
READ →GUILFORD, Conn., April 27, 2021 (GLOBE NEWSWIRE) — InveniAI® LLC, a global leader in pioneering the application of Artificial Intelligence (AI) and Machine Learning (ML) to transform innovation across…
READ →GUILFORD, Connecticut, and TOKYO, Japan, December 9, 2020 — InveniAI® LLC, a global leader in pioneering the application of artificial intelligence (AI) and machine learning (ML) to transform innovati…
READ →GUILFORD, Conn., September 9, 2020 — InveniAI® LLC (InveniAI), a global leader in pioneering the application of artificial intelligence (AI) and machine learning (ML) to transform drug discovery and d…
READ →GUILFORD, Conn., July 29, 2020 — InveniAI® LLC, a global leader in pioneering the application of artificial intelligence (AI) and machine learning (ML) to transform innovation across drug discovery an…
READ →GUILFORD, Conn., June 02, 2020 — InveniAI® LLC, a global leader pioneering the application of artificial intelligence (AI) and machine learning (ML) to transform innovation across drug discovery and d…
READ →GUILFORD, Conn., Nov. 06, 2019 — InveniAI® Corporation, a global leader pioneering the application of artificial intelligence (AI) and machine learning (ML) to transform innovation across healthcare a…
READ →GUILFORD, Conn., Sept. 17, 2019 — InveniAI® Corporation, a global leader pioneering the application of artificial intelligence (AI) and machine learning (ML) to transform innovation across healthcare …
READ →GUILFORD, Conn., July 02, 2019 (GLOBE NEWSWIRE) — InveniAI® Corporation, a global leader pioneering the application of artificial intelligence (AI) and machine learning (ML) to transform innovation ac…
READ →GUILFORD, CT., March 26, 2019 — InveniAI® Corporation, a global leader pioneering the application of artificial intelligence (AI) and machine learning (ML) to transform innovation across healthcare an…
READ →GUILFORD, Conn., Mar. 01, 2019 — InveniAI® Corporation, a global leader in pioneering the application of artificial intelligence (AI) and machine learning (ML) to transform innovation across healthcar…
READ →BRANFORD, CT December 11, 2018 — InveniAI® Corporation, a global leader in pioneering the application of artificial intelligence (AI) and machine learning (ML) to transform innovation across healthcar…
READ →